Call Us

ARTICLES

Arthrosamid®’s story started two decades ago. The brainchild of the team at Contura, the product had been in human use for various indications since 2000, and a favourable safety profile had already been established.

IRELAND’S ORTHOPAEDICS MARKET IS SET TO EMBRACE ‘INNOVATIVE AND EXCITING’ TREATMENT TO HELP EASE PAIN CAUSED BY KNEE OSTEOARTHRITIS

Arthrosamid is a polyacrylamide hydrogel developed by Contura International Ltd. as a long-lasting intra-articular injection approved in Europe for the treatment of knee osteoarthritis (OA). The treatment has the potential to change the present care pathway for managing osteoarthritis, which affects around one in four adults in Ireland aged over 601 (over 400,000 people)2 and current treatments are not long lasting or involve invasive knee replacement surgery. Despite a large suffering population, there has been very little innovation in the range of osteoarthritis treatments on offer to meaningfully help patients – until now.

Innovative Ways to Manage Patellofemoral Pain Syndrome: From Exercise Selection to Everyday Movement Strategies

Patellofemoral pain syndrome (PFPS), known as ‘runner’s knee,’ causes pain around the kneecap, affecting daily activities like walking and sitting. This condition often impacts young women and arises from muscle weakness, poor kneecap alignment, and overuse. Effective management includes targeted exercises—such as quadriceps strengthening and glute bridges—and lifestyle adjustments like proper sitting and sleeping postures. Early diagnosis and personalized treatment plans are essential, as some physical tests have limited sensitivity. While conservative treatments often relieve symptoms, persistent cases may require advanced interventions, including surgery. Utilizing evidence-based strategies and resources like NHS guides can help reduce PFPS discomfort and improve knee function, enabling a return to active, pain-free movement.

Read More »

The Science Behind Knee Gel Injections: How Synovial Fluid Supplements Relieve Osteoarthritis Pain

Knee gel injections, primarily hyaluronic acid-based, offer a minimally invasive treatment for osteoarthritis-related knee pain by replenishing natural joint lubrication and cushioning. These injections mimic synovial fluid to reduce friction, inflammation, and discomfort, enhancing mobility and daily activities. Various products like Synvisc, Euflexxa, and the newer polyacrylamide hydrogel Arthrosamid differ in formulation and duration of relief, with Arthrosamid showing promising longer-lasting effects up to 12 months. The injection process is simple and typically well-tolerated, making it suitable for moderate osteoarthritis cases unresponsive to other treatments. Consulting healthcare professionals is vital to tailor therapy for optimal results. This approach addresses joint health directly, improving quality of life by targeting the underlying lubrication loss in osteoarthritic knees.

Read More »